TARespirDis Profile Banner
Therapeutic Advances in Respiratory Disease Profile
Therapeutic Advances in Respiratory Disease

@TARespirDis

Followers
259
Following
226
Media
88
Statuses
704

Respiratory Disease | Impact Factor 3 | Indexed in: SCIE, MEDLINE, PMC, Scopus, DOAJ, ProQuest | Published by @SAGEJournals | #OpenAccess

SAGE Publishing, London, UK
Joined January 2019
Don't wanna be here? Send us removal request.
@TARespirDis
Therapeutic Advances in Respiratory Disease
4 months
🚨 We’re now on Bluesky! 🌤️. Follow Therapeutic Advances in Respiratory Disease on Bluesky for the latest research, expert insights, and updates in respiratory medicine. 🔗 Join us: #RespiratoryResearch #OpenScience
Tweet media one
0
0
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
7 days
RT @TheCQRC: Adjusting to life with a chronic disease, respiratory condition or other illness can be challenging. Identifying your symptoms….
0
1
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
7 days
RT @AlphaFriend: The Alphas of the Ozarks Support Group in Branson, MO, recently gathered to share experiences, build community, and learn….
0
2
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
15 days
RT @WHO: #Measles can be fatal. Do you know its symptoms?. 🔸 Rash that starts on the face and spreads over the body.🔸 Fever.🔸 Runny nose.🔸….
0
142
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
15 days
Can pulmonary function testing help predict outcomes after segmentectomy? Find out in this latest article in the journal!
Tweet media one
0
0
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
1 month
RT @EuropeanLung: AI is being used to improve understanding of #lunghealth. New research from @EuroRespSoc shows digital tools like #ChatGP….
0
1
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
1 month
Respiratory muscle training has shown varied results in patients suffering from acute or chronic respiratory failure. Read our latest systematic review and meta analysis on this intervention in patients with ALS.
Tweet media one
0
0
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
1 month
RT @EuroRespSoc: 🚨Registration closes next month! 🚨. Join the ERS experts for an upcoming research seminar: Regenerating the lung – a multi….
0
3
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
1 month
RT @SABronchoscopy: 🚨WATCH HERE NOW➡️Hear from Drs Dominique Pepper & Peter Lee as they discuss their experiences w….
0
2
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
What is the relationship between inhaler adherence and inhalation technique? 🤔. This latest study published in our journal asks this very question. #asthmaawareness
Tweet media one
0
0
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
RT @EuropeanLung: This #WorldBicycleDay, we are highlighting the power of physical activity in keeping our lungs healthy 🚴‍♂️🫁. 🚶 Walk or c….
0
3
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
RT @EuropeanLung: Attending a health conference like #ERSCongress? Want to make a real impact? 💡.Join our next #EPAPLive webinar to learn h….
0
2
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
RT @COPDCanada: As a member of Canada’s National Lung Health Alliance, COPD Canada applauds the World Health Organization and all of its Me….
0
1
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
Hot off the press 🔥.Monthly pulse dose steroids for patients with non-IPF pulmonary fibrosis. A shocking alternative to maintenance steroids.
Tweet media one
0
0
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
After seven world symposia and the recent addition of sotatercept to the arsenal of interventions, please read our latest review on the treatment of pulmonary hypertension!.#PHawareness.
Tweet media one
0
0
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
Congratulations to Dr. Dweik!.
@atscommunity
American Thoracic Society (ATS)
2 months
Renowned physician-scientist and leader @RaedDweikMD, MBA, ATSF, has begun his term as president of the American Thoracic Society. Dr. Dweik serves as chair of pulmonary and critical care medicine and enterprise chief of the Integrated Hospital Care Institute at the
Tweet media one
0
0
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
RT @PR_Assembly: Hello PCCM fellows and APDs! . Please consider taking the time to complete a survey that was emailed out to you yesterday….
0
2
0
@TARespirDis
Therapeutic Advances in Respiratory Disease
2 months
Walking is a historic form of physical exercise invented by human beings in the mammalian kingdom. Read this study about patients who led their own pre-operative conditioning program benefitting from ancestral wisdom and modern technology.
Tweet media one
0
0
1
@TARespirDis
Therapeutic Advances in Respiratory Disease
3 months
With how heterogenous interstitial lung diseases can be, it may be helpful to think of management in terms of treatable traits. Check out our article outlining this!.
Tweet media one
0
0
2
@TARespirDis
Therapeutic Advances in Respiratory Disease
3 months
Immunosuppression is a core part of managing interstitial lung diseases. Learn how outcomes differ between antisynthetase syndrome and systemic sclerosis in response to treatment!
Tweet media one
0
0
1
@TARespirDis
Therapeutic Advances in Respiratory Disease
3 months
RT @NIH: Today, NIH announced a new initiative to expand innovative, human-based science while reducing the use of animals in research. Thi….
nih.gov
New initiative aims to reduce use of animals in NIH-funded research.
0
257
0